Cargando…
Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci
Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739494/ https://www.ncbi.nlm.nih.gov/pubmed/34983823 http://dx.doi.org/10.26508/lsa.202101134 |
_version_ | 1784629111818289152 |
---|---|
author | Wong, Ka Man King, Devin A Schwartz, Erin K Herrera, Rafael E Morrison, Ashby J |
author_facet | Wong, Ka Man King, Devin A Schwartz, Erin K Herrera, Rafael E Morrison, Ashby J |
author_sort | Wong, Ka Man |
collection | PubMed |
description | Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) is regulated by both genetic and epigenetic factors. Importantly, carcinogen susceptibility is a critical contributor to cancer mutagenesis. It is known that mutations can be prevented by tumor suppressor regulation of DNA damage response pathways; however, their roles carcinogen susceptibility have not yet been reported. In this study, we reveal that the retinoblastoma (RB1) tumor suppressor regulates UV susceptibility across broad regions of the genome. In particular, centromere and telomere-proximal regions exhibit significant increases in UV lesion susceptibility when RB1 is deleted. Several cancer-related genes are located within genomic regions of increased susceptibility, including telomerase reverse transcriptase, TERT, thereby accelerating mutagenic potential in cancers with RB1 pathway alterations. These findings reveal novel genome stability mechanisms of a tumor suppressor and uncover new pathways to accumulate mutations during cancer evolution. |
format | Online Article Text |
id | pubmed-8739494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-87394942022-01-25 Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci Wong, Ka Man King, Devin A Schwartz, Erin K Herrera, Rafael E Morrison, Ashby J Life Sci Alliance Research Articles Carcinogenic insult, such as UV light exposure, creates DNA lesions that evolve into mutations if left unrepaired. These resulting mutations can contribute to carcinogenesis and drive malignant phenotypes. Susceptibility to carcinogens (i.e., the propensity to form a carcinogen-induced DNA lesion) is regulated by both genetic and epigenetic factors. Importantly, carcinogen susceptibility is a critical contributor to cancer mutagenesis. It is known that mutations can be prevented by tumor suppressor regulation of DNA damage response pathways; however, their roles carcinogen susceptibility have not yet been reported. In this study, we reveal that the retinoblastoma (RB1) tumor suppressor regulates UV susceptibility across broad regions of the genome. In particular, centromere and telomere-proximal regions exhibit significant increases in UV lesion susceptibility when RB1 is deleted. Several cancer-related genes are located within genomic regions of increased susceptibility, including telomerase reverse transcriptase, TERT, thereby accelerating mutagenic potential in cancers with RB1 pathway alterations. These findings reveal novel genome stability mechanisms of a tumor suppressor and uncover new pathways to accumulate mutations during cancer evolution. Life Science Alliance LLC 2022-01-04 /pmc/articles/PMC8739494/ /pubmed/34983823 http://dx.doi.org/10.26508/lsa.202101134 Text en © 2022 Wong et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles Wong, Ka Man King, Devin A Schwartz, Erin K Herrera, Rafael E Morrison, Ashby J Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title | Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title_full | Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title_fullStr | Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title_full_unstemmed | Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title_short | Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
title_sort | retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739494/ https://www.ncbi.nlm.nih.gov/pubmed/34983823 http://dx.doi.org/10.26508/lsa.202101134 |
work_keys_str_mv | AT wongkaman retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci AT kingdevina retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci AT schwartzerink retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci AT herrerarafaele retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci AT morrisonashbyj retinoblastomaproteinregulatescarcinogensusceptibilityatheterochromaticcancerdriverloci |